| SARS-CoV-2-mRNA booster vaccination reverses non-responsiveness and early antibody waning in immunocompromised patients–a phase four study comparing immune responses in … A Wagner, E Garner-Spitzer, AM Schötta, M Orola, A Wessely, I Zwazl, ... Frontiers in immunology 13, 889138, 2022 | 37 | 2022 |
| Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants P Gattinger, B Kratzer, I Tulaeva, K Niespodziana, A Ohradanova‐Repic, ... Allergy 77 (8), 2431-2445, 2022 | 25 | 2022 |
| Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense A Ohradanova-Repic, R Praženicová, L Gebetsberger, T Moskalets, ... Pharmaceutics 15 (4), 1056, 2023 | 17 | 2023 |
| Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin A Ohradanova-Repic, R Skrabana, L Gebetsberger, G Tajti, P Baráth, ... Frontiers in immunology 13, 958581, 2022 | 9 | 2022 |
| SARS-CoV-2-specific antibody (Ab) levels and the kinetic of ab decline determine ab persistence over 1 year E Garner-Spitzer, A Wagner, M Kundi, H Stockinger, A Ohradanova-Repic, ... Frontiers in Medicine 9, 822316, 2022 | 5 | 2022 |
| Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule. A Wagner, A Ohradanova-Repic, L Gebetsberger, G Tajti, M Kundi, ... Immunology Letters 250, 1-6, 2022 | 4 | 2022 |
| Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination A Wagner, E Garner-Spitzer, A Schötta, M Orola, A Wessely, I Zwazl, ... medRxiv, 2021.12. 13.21267603, 2021 | 3 | 2021 |
| Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type-and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron … P Gattinger, B Kratzer, ANA Sehgal, A Ohradanova-Repic, ... Vaccines 12 (3), 229, 2024 | 1 | 2024 |
| Vaccine Based on Recombinant Fusion Protein Combining HBV PreS with SARS-CoV-2 Wild-Type-and Omicron-Derived RBD Strongly Induces Omicron-Neutralizing Antibodies P Gattinger, B Kratzer, A Ohradanova-Repic, L Gebetsberger, G Tajti, ... Preprints, 2024 | 1 | 2024 |
| TLR2-mediated innate sensing of SARS-CoV-2 in circulating monocytes and NK cells G Tajti, L Gebetsberger, R Klasinc, C Battin, P Steinberger, H Stockinger, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 171-171, 2022 | | 2022 |
| Deciphering the host-cell protein content of SARS-CoV-2 virions L Gebetsberger, G Tajti, F Fontaine, T Hannich, A Mueller, H Stockinger, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 321-321, 2022 | | 2022 |
| Dissecting immunomodulatory effects of liposomal methotrexate, a potential next generation medicine for rheumatoid arthritis treatment A Ohradanova-Repic, E Nogueira, P Waidhofer-Soellner, L Gebetsberger, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 242-242, 2022 | | 2022 |
| Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by the N-terminal peptide of lactoferrin A Ohradanova-Repic, L Gebetsberger, G Tajti, G Ondrovičová, ... bioRxiv, 2021.12. 20.473447, 2021 | | 2021 |
